Search results (151)
« Back to PublicationsA comprehensive pharmacological survey across heterogeneous patient-derived glioblastoma stem cell models.
Journal article
Elliott RJR. et al, (2026), iScience, 29
Refined USP25/28 inhibitors with enhanced selectivity towards c-Myc driven squamous lung cancer cells
Preprint
Pinto-Fernández A. et al, (2026)
Therapeutic targeting of SETD2-deficient cancer cells with the small-molecule compound RITA
Preprint
Humphrey T. et al, (2026)
SoftHybrid: A Hybrid Imputation Algorithm Optimised for Single-Cell Proteomics Data
Preprint
Shi Y. et al, (2026)
Protocol for pooled FACS-based CRISPR knockout screening in human iPSC-derived microglia
Journal article
Washer SJ. et al, (2025), STAR Protocols, 6, 104111 - 104111
Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Supplementary Figure S3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Supplementary Figure S2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Supplementary Figure S5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Supplementary Figure S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Supplementary Figure S6 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)
Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2025)